NOVOCURE LTD's ticker is NVCR and the CUSIP is G6674U108. A total of 79 filers reported holding NOVOCURE LTD in Q4 2016. The put-call ratio across all filers is 0.06 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2018 | $177,000 | +7.9% | 8,112 | 0.0% | 0.00% | 0.0% |
Q4 2017 | $164,000 | +1.9% | 8,112 | 0.0% | 0.00% | 0.0% |
Q3 2017 | $161,000 | +15.0% | 8,112 | 0.0% | 0.00% | +33.3% |
Q2 2017 | $140,000 | +112.1% | 8,112 | 0.0% | 0.00% | +50.0% |
Q1 2017 | $66,000 | +3.1% | 8,112 | 0.0% | 0.00% | 0.0% |
Q4 2016 | $64,000 | – | 8,112 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
StepStone Group LP | 415,479 | $13,910,000 | 19.11% |
HARTLINE INVESTMENT CORP/ | 405,066 | $13,562,000 | 4.13% |
APIS CAPITAL ADVISORS, LLC | 81,100 | $2,715,000 | 3.64% |
Darsana Capital Partners LP | 2,150,000 | $71,982,000 | 3.01% |
Rhenman & Partners Asset Management AB | 545,000 | $18,247,000 | 2.09% |
Taylor Frigon Capital Management LLC | 43,686 | $1,463,000 | 1.29% |
COURAGE CAPITAL MANAGEMENT LLC | 40,000 | $1,339,000 | 1.04% |
Tygh Capital Management, Inc. | 127,973 | $4,285,000 | 0.90% |
Granite Investment Partners, LLC | 332,667 | $11,138,000 | 0.81% |
Steinberg Global Asset Management | 135,394 | $4,533,000 | 0.78% |